1. A JAK3/STAT3 passenger activation in a lapatinib-acquired resistance model of HER2-amplified breast cancer. (March 2017) Authors: Van Bockstal, M.; Van Roy, N.; Vergauwen, G.; Lambein, K.; Cocquyt, V.; Libbrecht, L.; Denys, H.; Bracke, M.; De Wever, O. Journal: Breast Issue: Volume 32(2017)Supplement 1 Page Start: S48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. BELGIAN SPECIALISTS' VIEW ON THE ADJUVANT TREATMENT OF HORMONE-DEPENDENT NON-METASTATIC BREAST CANCER?. Issue 1 (1st March 2003) Authors: Leunen, K.; Neven, P.; Lifrange, E.; Nolens, J. P.; Cocquyt, V. Journal: International journal of gynecological cancer Issue: Volume 13:Issue 1(2003) Supplement Page Start: 90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Incorporating PARP-inhibitors into clinical routine: A tailored treatment strategy to tackle ovarian cancer. Issue 1 (2nd January 2017) Authors: De Jaeghere, E.; Vandecasteele, K.; Claes, K.; Makar, A.; Tummers, P.; Cocquyt, V.; Denys, Hannelore Journal: Acta clinica belgica Issue: Volume 72:Issue 1(2017) Page Start: 6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗